Amgen
Amgen Inc., a leading biotechnology company headquartered in the United States, has been at the forefront of innovation since its founding in 1980. With a strong presence in major operational regions including Europe and Asia, Amgen focuses on developing therapies in areas such as oncology, nephrology, and inflammation.
Renowned for its pioneering biologic medicines, Amgen's core products include Enbrel, Neulasta, and Prolia, which are distinguished by their ability to target specific disease pathways effectively. The company has achieved significant milestones, including the introduction of the first recombinant human erythropoietin, Epogen, which transformed the treatment of anaemia.
As a prominent player in the biotechnology industry, Amgen continues to excel, holding a strong market position and receiving numerous accolades for its commitment to scientific excellence and patient care.
+1 vs industry average
Amgen’s score of 39 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Amgen?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Amgen's reported carbon emissions
In 2024, Amgen reported total carbon emissions of approximately 1.8 billion kg CO2e, comprising 147,353,000 kg CO2e from Scope 1, 14,000,000 kg CO2e from Scope 2, and 1,705,000,000 kg CO2e from Scope 3 emissions. This data reflects a comprehensive approach to emissions reporting, including all relevant scopes. Amgen has set ambitious climate commitments, aiming for a 55% reduction in absolute Scope 1 and 2 greenhouse gas emissions by 2027, using a 2019 baseline. The company also plans to achieve 100% renewable electricity sourcing across its operations by 2027, which is expected to result in a significant reduction of approximately 50% in carbon emissions from operations. As of 2023, Amgen has achieved 54% of its targeted reductions for Scope 1 and 2 emissions. Additionally, Amgen is committed to ensuring that 73% of its suppliers, by spend, covering upstream purchased goods and services and capital goods, will have science-based targets by 2027. This commitment aligns with the Science Based Targets initiative (SBTi) and underscores Amgen's dedication to sustainability within its supply chain. Overall, Amgen's climate strategy reflects a robust commitment to reducing its carbon footprint and promoting sustainability in the pharmaceutical and biotechnology sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Amgen’s Climate Goals (2030 & 2050)
2 goals2027
By 2027, achieve carbon neutrality for Amgen-owned and opera…
By 2027, achieve carbon neutrality for Amgen-owned and operated facilities and operations.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project